你即將離開本站

並前往https://www.fiercebiotech.com/biotech/gsk-coughs-2b-stop-coughs-buying-bellus-late-phase-rival-mercks-stuttering-therapy

GSK coughs up $2B to buy Bellus for late-phase rival to Merck ...

Merck & Co. has a new challenger for the chronic cough market: GSK. ... when the failure of a midphase camlipixant trial sent its stock spiraling downward, ...

確定！ 回上一頁

查詢 「Merck Co stock」的人也找了：

  1. Metaverse stock
    2.
  2. Modern stock
    3.
  3. T stock
    4.
  4. JNJ stock
    5.
  5. Intel stock
    6.
  6. Red Bull stock
    7.
  7. Bing stock
    8.
  8. Pfizer stock
    9.